Search by Drug Name or NDC
NDC 50090-5834-00 Cabergoline 0.5 mg/1 Details
Cabergoline 0.5 mg/1
Cabergoline is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by A-S Medication Solutions. The primary component is CABERGOLINE.
MedlinePlus Drug Summary
Cabergoline is used to treat hyperprolactinemia (high levels of prolactin, a natural substance that helps breast-feeding women produce milk but can cause symptoms such as infertility, sexual problems, and bone loss in women who are not breast-feeding or men). Cabergoline is in a class of medications called dopamine receptor agonists. It works by decreasing the amount of prolactin in the body.
Related Packages: 50090-5834-00Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Cabergoline
Product Information
| NDC | 50090-5834 |
|---|---|
| Product ID | 50090-5834_2f4ab4e8-63aa-4382-90e7-7657b52c69f9 |
| Associated GPIs | 30402020000320 |
| GCN Sequence Number | 025738 |
| GCN Sequence Number Description | cabergoline TABLET 0.5 MG ORAL |
| HIC3 | P1F |
| HIC3 Description | PITUITARY SUPPRESSIVE AGENTS |
| GCN | 26051 |
| HICL Sequence Number | 010803 |
| HICL Sequence Number Description | CABERGOLINE |
| Brand/Generic | Generic |
| Proprietary Name | Cabergoline |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Cabergoline |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 0.5 |
| Active Ingredient Units | mg/1 |
| Substance Name | CABERGOLINE |
| Labeler Name | A-S Medication Solutions |
| Pharmaceutical Class | Ergolines [CS], Ergot Derivative [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA204735 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 50090-5834-00 (50090583400)
| NDC Package Code | 50090-5834-0 |
|---|---|
| Billing NDC | 50090583400 |
| Package | 8 TABLET in 1 BOTTLE (50090-5834-0) |
| Marketing Start Date | 2021-10-27 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |